Stocktoria

NEUTRA CORP. NTRR

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2011-07-12

NEUTRA CORP. (NTRR) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2023 revenue was $67,996 at a -825.7% net margin.

4/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$0.00 as of 2026-06-01 · -66.7% 1y
$0.00$0.0052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Net margin-825.7%
Revenue trend · last 3y · up

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 45%
Net marginstronger than 11%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
NTRRNEUTRA CORP.4/9
NPHCNUTRA PHARMA CORP3/9
RAJAFCordyceps Sunshine Biotech Holdings Co., Ltd.4/9-6.82
PLSHPANACEA LIFE SCIENCES HOLDINGS, INC.4/9-13.95
FTLFFITLIFE BRANDS, INC.3/91.9951.6-75.3%
BONBon Natural Life Ltd4/94.25-21.7%
CHUCCharlie's Holdings, Inc.3/9-1.3513.2

All Manufacturing companies →

FAQ

Is NTRR financially healthy?

NEUTRA CORP.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).

Does NTRR pay a dividend?

No, NEUTRA CORP. does not currently pay a dividend.

How profitable is NTRR?

In FY2023, NEUTRA CORP. had a net margin of -825.7%.

Source: SEC EDGAR filings · CIK 0001512886 · US · as of 2023-01-31. facts plus Stocktoria's own computed scores — not investment advice.